These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 24431836)
41. Patient Satisfaction with AbobotulinumtoxinA for Aesthetic Use in the Upper Face: A Systematic Literature Review and Smit R; Gubanova E; Kaufman J; Landau M; Molina B; Andriopoulos B; Maisonobe P; Prygova I; Redaelli A J Clin Aesthet Dermatol; 2021 Feb; 14(2):E69-E88. PubMed ID: 34221231 [No Abstract] [Full Text] [Related]
42. Double-blind, placebo-controlled study of the safety and efficacy of botulinum toxin type A for patients with glabellar lines. Carruthers JD; Lowe NJ; Menter MA; Gibson J; Eadie N; Plast Reconstr Surg; 2003 Sep; 112(4):1089-98. PubMed ID: 12973229 [TBL] [Abstract][Full Text] [Related]
43. Consensus recommendations on the use of botulinum toxin type a in facial aesthetics. Carruthers J; Fagien S; Matarasso SL; Plast Reconstr Surg; 2004 Nov; 114(6 Suppl):1S-22S. PubMed ID: 15507786 [TBL] [Abstract][Full Text] [Related]
44. Eighteen-point abobotulinum toxin a upper face rejuvenation: an eye plastic perspective on 845 subjects. Kashkouli MB; Amani A; Jamshidian-Tehrani M; Yousefi S; Jazayeri AA Ophthalmic Plast Reconstr Surg; 2014; 30(3):219-24. PubMed ID: 24481513 [TBL] [Abstract][Full Text] [Related]
45. Safe Glabellar Wrinkle Correction With Soft Tissue Filler Using Doppler Ultrasound. Lee W; Moon HJ; Kim JS; Yang EJ Aesthet Surg J; 2021 Aug; 41(9):1081-1089. PubMed ID: 32644130 [TBL] [Abstract][Full Text] [Related]
46. Comparison of the Clinical Efficacy of Abobotulinumtoxin A (ABO) and Onabotulinumtoxin A (ONA) in the Treatment of Crow's Feet Wrinkles: A Split-Face Study. Elridy AS; Zaki RGE; Elshinawy RF Semin Ophthalmol; 2018; 33(6):739-747. PubMed ID: 29278961 [TBL] [Abstract][Full Text] [Related]
47. Intraoperative injection of botulinum toxin A into orbicularis oculi muscle for the treatment of crow's feet. Guerrissi JO Plast Reconstr Surg; 2000 May; 105(6):2219-25; discussion 2226-8. PubMed ID: 10839423 [TBL] [Abstract][Full Text] [Related]
48. Full-face injections of variable total doses of abobotulinum toxin type A: A randomized, phase IV clinical trial of safety and efficacy. Hexsel D; Brum C; Porto MD; Soirefmann M; Siega C; Schilling-Souza J; Rodrigues TC J Drugs Dermatol; 2013 Dec; 12(12):1356-62. PubMed ID: 24301236 [TBL] [Abstract][Full Text] [Related]
49. A double-blinded, randomized, placebo-controlled pilot study of the safety and efficacy of Myobloc (botulinum toxin type B)-purified neurotoxin complex for the treatment of crow's feet: a double-blinded, placebo-controlled trial. Baumann L; Slezinger A; Vujevich J; Halem M; Bryde J; Black L; Duncan R Dermatol Surg; 2003 May; 29(5):508-15. PubMed ID: 12752519 [TBL] [Abstract][Full Text] [Related]
50. Botulinum toxin type A versus botulinum toxin type B for cervical dystonia. Duarte GS; Castelão M; Rodrigues FB; Marques RE; Ferreira J; Sampaio C; Moore AP; Costa J Cochrane Database Syst Rev; 2016 Oct; 10(10):CD004314. PubMed ID: 27782297 [TBL] [Abstract][Full Text] [Related]
51. Supraciliary wrinkles and botulinum toxin A. Ghalamkarpour F; Robati RM; Aryanejad F; Toossi P Clin Exp Dermatol; 2010 Jun; 35(4):388-91. PubMed ID: 19874314 [TBL] [Abstract][Full Text] [Related]
52. Long-term prospective follow-up of botulinum toxin treatment for facial rhytides. Bulstrode NW; Grobbelaar AO Aesthetic Plast Surg; 2002; 26(5):356-9. PubMed ID: 12432474 [TBL] [Abstract][Full Text] [Related]
53. Prospective open-label study of botulinum toxin type B (Myobloc) at doses of 2,400 and 3,000 U for the treatment of glabellar wrinkles. Sadick NS Dermatol Surg; 2003 May; 29(5):501-7; discussion 507. PubMed ID: 12752518 [TBL] [Abstract][Full Text] [Related]
54. The cosmetic use of botulinum toxin type B in the upper face. Sadick NS Clin Dermatol; 2004; 22(1):29-33. PubMed ID: 15158542 [TBL] [Abstract][Full Text] [Related]
56. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Repeated OnabotulinumtoxinA Treatments in Subjects With Crow's Feet Lines and Glabellar Lines. Carruthers J; Rivkin A; Donofrio L; Bertucci V; Somogyi C; Lei X; Davis PG; Campo A; Beddingfield FC Dermatol Surg; 2015 Jun; 41(6):702-11. PubMed ID: 25993609 [TBL] [Abstract][Full Text] [Related]
58. Safety and effectiveness of small and large gel-particle hyaluronic acid in the correction of perioral wrinkles. Brandt F; Bassichis B; Bassichis M; O'Connell C; Lin X J Drugs Dermatol; 2011 Sep; 10(9):982-7. PubMed ID: 22052266 [TBL] [Abstract][Full Text] [Related]
59. Intraoperative Injection of Botulinum Toxin A into Orbicularis Oculi Muscle for the Treatment of Crow's Feet. Guerrissi JO Plast Reconstr Surg; 2000 May; 104(6):2219-2225. PubMed ID: 11242328 [TBL] [Abstract][Full Text] [Related]
60. Botulinum toxin A (Botox Cosmetic): a review of its use in the treatment of glabellar frown lines. Frampton JE; Easthope SE Am J Clin Dermatol; 2003; 4(10):709-25. PubMed ID: 14507232 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]